These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records. Nakagawa N, Kimura T, Sakate R, Wada T, Furuichi K, Okada H, Isaka Y, Narita I. Sci Rep; 2023 Sep 07; 13(1):14771. PubMed ID: 37679492 [Abstract] [Full Text] [Related]
10. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series. Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A. BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111 [Abstract] [Full Text] [Related]
13. The influences of larger physical constitutions including obesity on the amount of urine protein excretion in primary glomerulonephritis: research of the Japan Renal Biopsy Registry. Yonekura Y, Goto S, Sugiyama H, Kitamura H, Yokoyama H, Nishi S. Clin Exp Nephrol; 2015 Jun 31; 19(3):359-70. PubMed ID: 24916004 [Abstract] [Full Text] [Related]
15. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series. Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF. Am J Kidney Dis; 2017 May 31; 69(5):637-646. PubMed ID: 28089478 [Abstract] [Full Text] [Related]
16. Clinicopathologic correlation and outcome of C1q nephropathy. Hisano S, Fukuma Y, Segawa Y, Niimi K, Kaku Y, Hatae K, Saitoh T, Takeshita M, Iwasaki H. Clin J Am Soc Nephrol; 2008 Nov 31; 3(6):1637-43. PubMed ID: 18650410 [Abstract] [Full Text] [Related]
17. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G. Nephrol Dial Transplant; 2002 Nov 31; 17(11):1890-6. PubMed ID: 12401843 [Abstract] [Full Text] [Related]
20. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions. Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM. Rev Assoc Med Bras (1992); 2024 Nov 31; 70(4):e20230871. PubMed ID: 38716932 [Abstract] [Full Text] [Related] Page: [Next] [New Search]